Observation on therapeutic effect of sequential therapy with levofloxacin on community acquired pneumonia
Abstract
Objective To evaluate the efficacy of sequential treatment of levofloxacin on community acquired pneumonia.Methods 96 patients with community acquired pneumonia were divided into levofloxacin group(49 patients)and control group(47 patients treated with Cefuroxime sodium plus azithromycin),the drugs were given sequentially by intravenous infusion for 3 days,then changed to oral administration for 7 to 14 days.Their clinical symptoms,signs,chest X-ray examination and laboratory findings were observed and compared in these 2 groups.Results There was no significant difference in efficacy rate between these two groups;there were less adverse reactions in levofloxacin group.Conclusion Sequential therapy of levofloxacin for community acquired pneumonia was reliable.Levofloxacin may be offered as an alternative to clinicians for treatment of community acquired pneumonia.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.